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Abstract
Increasing age and lower pre-operative Glasgow coma score (GCS) are associated with worse outcome after surgery for chronic
subdural haematoma (CSDH). Only few studies have quantified outcomes specific to the very elderly or comatose patients. We aim
to examine surgical outcomes in these patient groups. We analysed data from a prospective multicentre cohort study, assessing the
risk of recurrence, death, and unfavourable functional outcome of very elderly (≥ 90 years) patients and comatose (pre-operative
GCS ≤ 8) patients following surgical treatment of CSDH. Seven hundred eighty-five patients were included in the study. Thirty-two
(4.1%) patients had pre-operative GCS ≤ 8 and 70 (8.9%) patients were aged ≥ 90 years. A higher proportion of comatose patients
had an unfavourable functional outcome (38.7 vs 21.7%; p = 0.03), although similar proportion of comatose (64.5%) and non-
comatose patients (61.8%) functionally improved after surgery (p = 0.96). Compared to patients aged < 90 years, a higher propor-
tion of patients aged ≥ 90 years had unfavourable functional outcome (41.2 vs 20.5%; p < 0.01), although approximately half had
functional improvement following surgery. Mortality risk was higher in both comatose (6.3 vs 1.9%; p = 0.05) and very elderly (8.8
vs 1.1%; p < 0.01) groups. There was a trend towards a higher recurrence risk in the comatose group (19.4 vs 9.5%; p = 0.07).
Surgery can still provide considerable benefit to very elderly and comatose patients despite their higher risk of morbidity and
mortality. Further research would be needed to better identify those most likely to benefit from surgery in these groups.
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Introduction
Chronic subdural haematoma (CSDH) is a common neurosur-
gical condition whose incidence and prevalence increase with
age [1–4]. Surgical drainage is the gold standard treatment for
the management of symptomatic CSDH [5, 6]. Longitudinal
studies have consistently demonstrated that age and pre-
operative Glasgow coma score (GCS) are associated with
worse surgical outcomes [7, 8]. However, whilst older patients
and comatose patients are in a poorer prognostic group, the
outcomes specific to these patients are not well studied.
Quantifying these would inform clinical judgement.
With an ageing population, determining the optimal man-
agement of CSDH in older people is of increasing importance.
Whilst the median age of patients admitted to neurosurgical
units (NSUs) for surgery is 77 [9], no consensus currently
exists in the management of very elderly patients with
CSDH (≥ 90 years old). Surgery may hence be delayed or
refused, because of the increased risk of perioperative morbid-
ity and mortality and the perception of an expected likelihood
Edward Christopher and Michael T. C. Poon contributed equally to this
work.
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s10143-018-0979-4) contains supplementary
material, which is available to authorized users.
* Paul M. Brennan
paul.brennan@ed.ac.uk
1 College of Medicine and Veterinary Medicine, University of
Edinburgh, Edinburgh, UK
2 Translational Neurosurgery, Centre for Clinical Brain Sciences,
University of Edinburgh and Western General Hospital,
Edinburgh, UK
3 Department of Neurosurgery, Queen’s Medical Centre,
Nottingham, UK
4 Division of Neurosurgery, Department of Clinical Neurosciences,
University of Cambridge and Addenbrooke’s Hospital,
Cambridge, UK
5 Surgery Theme, Cambridge Clinical Trials Unit, Cambridge
Biomedical Campus, Cambridge, UK
6 Department of Clinical Neurosciences, Western General Hospital,
Edinburgh, UK
Neurosurgical Review (2019) 42:427–431
https://doi.org/10.1007/s10143-018-0979-4
of uniformly poor outcomes [10]. Paradoxically, this vulnera-
ble group may benefit most from urgent surgery [10].
Uncertainties also remain as to whether comatose patients
should undergo surgery at all.
In this study, we analysed data from a prospective
multicentre cohort study to assess the risk of recurrence, risk
of death, and functional outcome of patients aged ≥ 90 and
comatose patients following surgical drainage of CSDH, to
inform decision-making in this population.
Methods
The detailed study protocol for the prospective multicentre
study has been published previously [9, 11]. Briefly, this
was a prospective multicentre cohort study in the UK and
Ireland that aimed to describe the perioperative clinical char-
acteristics and short-term outcomes of patients with CSDH.
There were 26 NSUs recruiting patients during the study pe-
riod between May 2013 and January 2014. Patients were eli-
gible for the study if they were (1) ≥ 16 years of age; (2)
diagnosed with a primary or recurrent CSDH confirmed on
neuroimaging; and (3) referred to a NSU. CSDH was radio-
logically defined as a primarily hypodense, isodense, or
mixed-density subdural collection. Patients were excluded
from the study if other pathologies (e.g. subdural empyema,
vascular malformations) were identified during operation or
during subsequent management. There were no pre-specified
criteria for offering surgery to patients with CSDH; the deci-
sion was made by the respective consultant neurosurgeon on
duty. Patient data recorded included demographics (age and
gender), baseline characteristics (comorbidities, history of
head injury, antithrombotic drug use, pre-operative clinical
status), and perioperative management (platelet transfusion,
vitamin K use, operation lateralization, operation type, drain
insertion, and post-operative bed rest instructions). Data was
stored using a secure online database that complies with the
Department of Health Information Governance policies. Each
NSU had received local clinical governance approval.
Outcome measures
For this current study, patients with a pre-operative GCS of ≤ 8
were considered as comatose. Patients aged ≥ 90 years were
considered as very elderly. Data from these patients was ex-
tracted from the master database for analysis. Outcome mea-
sures included recurrence, functional status at discharge, and
mortality. We defined recurrence as radiologically confirmed
symptomatic recurrence requiring re-operation within 60 days
of index admission. There were two functional status outcome
measures. First was the early absolute functional status as
measured using the modified Rankin Scale (mRS) on dis-
charge from NSU. A score of 0–3 had been pre-specified as
favourable, whilst 4–6 as unfavourable. Second is a relative
functional improvement comparing the mRS on discharge
with the pre-operative mRS. This measure was defined post
hoc and was not included in the original protocol [9, 11].
Mortality was defined as death due to any cause that occurred
during admission in the NSU.
Statistical methods
Baseline characteristics were compared using parametric and
non-parametric tests as appropriate. We used chi-square or
Fisher’s exact test to compare outcome measures between
groups. Wilcoxon paired test was used to compare pre- and
post-operative mRS scores within a group. The number of
available outcomes precludes multivariate analyses. All statis-
tical analyses were performed using Stata version 13.0
(StataCrop).
Results
Data was collected for 1205 patients with CSDH referred to 26
NSUs. Seven hundred eighty-five patients (65.1%) were sub-
sequently accepted for NSU admission upon referral and were
included in our study. Of these 785 patients, 32 patients (4.1%)
had GCS ≤ 8 and 70 patients (8.9%) were ≥ 90 years of age.
Patients with GCS ≤ 8 undergoing surgery
Baseline characteristics of patients
with pre-operative GCS ≤ 8
There were 32 patients with pre-operative GCS ≤ 8. The base-
line characteristics of these patients are presented in Online
Resource 1. Characteristics of comatose patients were similar
to non-comatose patients. Age, gender, comorbidities, and
peri-operative management were similar between the two
groups. We were unable to compare the baseline characteris-
tics of comatose patients who were transferred with those who
stayed in the referring hospital, as detailed data was not col-
lected for patients not transferred to NSU.
Outcomes of patients with pre-operative GCS ≤ 8
Table 1 summarises outcomes in comatose patients. Two
(6.3%) deaths occurred in the comatose group compared with
the 14 (1.9%) deaths in the non-comatose group (p = 0.05).
There were six (19.4%) recurrences occurring within 60 days
in the comatose group; there was a trend of higher recurrence
risk in the comatose group compared with the risk in the non-
comatose group (9.5%) (p = 0.07). The proportion of patients
with unfavourable functional outcome (discharge mRS 4–6) in
the comatose group was higher than that in the non-comatose
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group (p = 0.03). However, comparing the initial mRSwith the
discharge mRS using paired analyses, there was a significant
improvement in functional status in both comatose and non-
comatose groups following surgery (p < 0.01). A similar pro-
portion of comatose and non-comatose patients functionally
improved after surgery (p = 0.96).
Patients aged ≥ 90 years undergoing surgery
Baseline characteristics of patients aged ≥ 90 years
The baseline characteristics of the 70 patients aged ≥ 90 years
are presented in Online Resource 2. Characteristics of patients
aged ≥ 90 years were similar to patients aged < 90 years ex-
cept the older group having less male predominance (p =
0.02), higher proportion of patients reporting a history of head
injury within the preceding 3 months (p < 0.01), lower pre-
operative functional status (p < 0.01), lower pre-operative
GCS (p = 0.04), and more likely to have undergone an opera-
tion under local anaesthesia (p < 0.01). Comorbidities and
peri-operative management were otherwise similar between
the two groups. We were unable to compare the baseline char-
acteristics of patients aged ≥ 90 years who were transferred
with those who stayed in the referring hospital, as detailed
data were not collected for patients not transferred to NSU.
Outcomes of patients aged ≥ 90 years
Table 2 summarises the outcomes in the older and younger
groups of patients. Six (8.8%) deaths occurred in the older
group compared with eight (1.1%) in the younger group
(p < 0.01). There was no difference in the risk of recurrence
between the older group (11.8%) and the younger group
(9.8%) (p = 0.60). In the older group, there were 28 (41.2%)
patients with an unfavourable functional outcome at discharge
and 35 (51.5%) patients with no functional improvement at
discharge. These proportions were significantly higher than in
the younger group (p < 0.01). However, comparing the initial
mRS with the discharge mRS using paired analyses, there was
a significant improvement in functional status in both older
and younger groups following surgery (p < 0.01).
In our cohort, there were three patients aged ≥ 90 years
presenting in a coma. They all had poor functional status
pre-operatively. One patient died; the remaining had same or
worse functional outcome following surgery.
Discussion
About a tenth of the patients referred to neurosurgery were ≥
90 years of age in our study, which is similar to a population-
based study [12]. Similar to our findings, previous studies
have reported increased mortality following CSDH surgery
in patients aged ≥ 90 years [7, 8, 13–15]. We also found that
a higher proportion of patients aged ≥ 90 years had
unfavourable outcome and about half did not have functional
improvement post-operatively. Multiple comorbidities, re-
duced physiological reserve, worse pre-morbid functional sta-
tus, and the natural increased risk of death in very elderly
people are all factors that are likely to contribute towards this.
We also found that increasing age does not appear to be asso-
ciated with increased recurrence risk, consistent with previous
studies [9, 12, 16–20].
In addition to higher mortality, patients aged ≥ 90 years had
worse functional outcome compared to younger patients. In
fact, in a recent large Japanese population-based study, anal-
ysis of a subgroup of 5414 patients aged ≥ 90 found that
56.8% had a poor outcome (mRS 3–6) and under 40% of them
were discharged home [12]. Whilst patients aged ≥ 90 had
worse functional status pre-operatively, our findings support
this observation. Our findings also demonstrate an overall
significant improvement in functional status after surgery in
the paired analyses. This benefit from surgery was not seen in
all very elderly patients. It is also not possible to know from
our data whether these functional improvements were
Table 1 Summary table of
outcome measures in comatose
and non-comatose groups.
Patients with incomplete data
were excluded from analyses
Number of events n/N (%) p value
Comatose group Non-comatose group
Recurrence within 60 days 6/31 (19.4) 70/733 (9.5) 0.07
Discharge mRS 4–6 12/31 (38.7) 159/733 (21.7) 0.03
No functional improvement 11/31 (35.5) 280/733 (38.2) 0.96
Death 2/32 (6.3) 14/753 (1.9) 0.05
Table 2 Summary table of outcome measures in older and younger
patients. Patients with incomplete data were excluded from analyses
Number of events n/N (%) p value
Age ≥ 90 years Age < 90 years
Recurrence within 60 days 8/68 (11.8) 68/696 (9.8) 0.60
Discharge mRS 4–6 28/68 (41.2) 143/696 (20.5) < 0.01
No functional improvement 35/68 (51.5) 239/696 (34.3) < 0.01
Death 6/68 (8.8) 8/696 (1.1) < 0.01
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sufficient to impact on the patient’s quality of life. Future
studies should aim to identify factors that predict which very
elderly patients are most likely to make functional benefits.
We could not exclude further improvements made by very
elderly patients following their discharge from hospital; how-
ever, mid-term and long-term data were not collected as part
of this study.
Under 3% of all the referred patients in this cohort were in
coma (GCS ≤ 8), which is similar to a Scandinavian
population-based cohort [17]. Other studies based in Iran
[16] and India [7] reported a much higher proportion of co-
matose patients (10 and 14% respectively), presumably
reflecting variations in referral practices. We found that coma-
tose patients had worse functional outcome at discharge and
higher mortality risk compared to non-comatose patients.
Previous single-institutional retrospective study with a sub-
group of 92 surgically treated comatose patients reported
30% death and 35% moderate to severe disability risk [7].
This can be explained by their worse functional baseline on
admission, since pre-operative mRS is a predictor of post-
operative outcome [9]. We also observed a trend towards
higher recurrence risk in comatose patients which did not
reach statistical significance.
Nonetheless, in a subset of comatose patients, there may be
benefit to surgery. In the paired analyses, we found an overall
significant improvement in functional status following sur-
gery in comatose patients. Duration of coma and pupillary
reaction could influence surgical outcome in comatose pa-
tients [21] and this may explain why surgery was not benefi-
cial in all comatose patients. Duration of coma and pupillary
reaction were not collected as part of this study and we were
therefore unable to confirm nor refute these relationships.
Interestingly, similar proportions of comatose and non-
comatose patients functionally improved following surgery.
Low GCS is associated with poorer outcomes [7, 8], but
should not be used for patient selection alone. The context
of the patient’s overall condition is important.
Overall, our findings support the notion that comatose and
very elderly patients with CSDH are at a higher risk of mor-
bidity andmortality from surgery. However, advanced age and
low GCS do not preclude clinical improvement and so these
patients should not be routinely denied surgery. With im-
proved understanding of the pathophysiology of CSDH [22,
23], effective non-surgical therapies may potentially obviate
the need for surgery in these vulnerable patient groups. But for
now, non-surgical management provides little to no functional
improvement [13, 14]. Surgery remains the gold standard
treatment for the management of symptomatic CSDH [5, 6].
Although we have demonstrated that surgery can signifi-
cantly improve outcomes for the very elderly and comatose,
patients will vary in their acceptance of the trade-off against
surgical risk [24, 25]. The impact on outcomes following
surgery reported in recent randomised controlled trials such
as DECRA [26] and RESCUEicp [27] have highlighted that
patients’ opinion on whether a particular surgical outcome is
considered as improvement or not will vary. Our data will
assist clinicians in providing patients, their relatives, and their
carers with a realistic assessment of the likely benefits of
surgery.
Our study has several limitations. There are differences in
baseline characteristics in the subgroups of interest and their
comparison groups. Analyses adjusting for potential con-
founders were not possible due to the few outcome events in
the small subgroups, which prevented multivariate analyses.
This study design did not record the criteria for patient selec-
tion and these criteria are likely to be different between NSUs.
Because of this, we were unable to comment on or recom-
mend factors to consider when assessing patients in these
high-risk groups. Further research would be needed in order
to better identify pre-operatively which comatose and very
elderly patients are likely to benefit the most from surgery.
Our dichotomy of age groups did not lend us to examine the
association between increasing age and outcome, though this
was not our objective. Although we are able to focus on the
high-risk groups of patients aged ≥ 90 years or in a coma, fully
adjusted analyses to examine outcomes were not achievable
due to paucity of outcome events. We were unable to examine
patients aged ≥ 90 years who are comatose due to small patient
numbers. Future studies should explore this combined high-
risk group. Our study design did not allow longer term
following-up of these patients beyond 60 days.
In conclusion, patients aged ≥ 90 years or are comatose pre-
operatively are in a high-risk group with increased mortality
and morbidity. Surgical management has a role in achieving
more favourable outcomes in carefully selected patients. The
challenge is to develop a strategy to identify those who will
improve with surgery from those who will not.
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